Status:
COMPLETED
Testosterone in Female Hypoactive Sexual Desire Disorder
Lead Sponsor:
Beersheva Mental Health Center
Conditions:
Hypoactive Sexual Desire Disorder
Eligibility:
FEMALE
21-40 years
Phase:
PHASE3
Brief Summary
The success of sildenafil in the treatment of erectile dysfunction has led to efforts to find similar treatments for prevalent disorders of female sexual dysfunction. Daily transdermal testosterone ha...
Detailed Description
The role of androgens in addition to estrogens in female sexual health has been known for several decades \[Davis and Tran 2001\]. Recently methods of delivering testosterone other than by injection h...
Eligibility Criteria
Inclusion
- pre-menopausal females, hypoactive sexual disorder, age 21-40, able to plan intercourse with partner -
Exclusion
- \-
Key Trial Info
Start Date :
April 1 2005
Trial Type :
INTERVENTIONAL
End Date :
April 1 2006
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT00140153
Start Date
April 1 2005
End Date
April 1 2006
Last Update
November 25 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Beersheva Mental Health Center
Beersheva, Israel